Search

Gwendolyn Wrenn Baxter

Examiner (ID: 2103, Phone: (571)272-6814 , Office: P/3632 )

Most Active Art Unit
3632
Art Unit(s)
3505, 3623, 3632
Total Applications
1606
Issued Applications
1206
Pending Applications
55
Abandoned Applications
352
Applications
StatisticsSubscription-Only

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6178702 [patent_doc_number] => 20020156264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => '22012, a novel human carboxypeptidase' [patent_app_type] => new [patent_app_number] => 10/068134 [patent_app_country] => US [patent_app_date] => 2002-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 27744 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156264.pdf [firstpage_image] =>[orig_patent_app_number] => 10068134 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/068134 		22012, a novel human carboxypeptidase Feb 5, 2002 Abandoned
Array ( [id] => 6779361 [patent_doc_number] => 20030050443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Prostate specific secreted protein' [patent_app_type] => new [patent_app_number] => 10/054976 [patent_app_country] => US [patent_app_date] => 2002-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 49323 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050443.pdf [firstpage_image] =>[orig_patent_app_number] => 10054976 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/054976 		Prostate specific secreted protein Jan 24, 2002 Abandoned
Array ( [id] => 6442093 [patent_doc_number] => 20020128463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Novel human mitochondrial membrane protein' [patent_app_type] => new [patent_app_number] => 10/038302 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17655 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128463.pdf [firstpage_image] =>[orig_patent_app_number] => 10038302 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/038302 		Novel human mitochondrial membrane protein Jan 3, 2002 Abandoned
Array ( [id] => 7034520 [patent_doc_number] => 20050033030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Humanised antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/433349 [patent_app_country] => US [patent_app_date] => 2001-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3717 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20050033030.pdf [firstpage_image] =>[orig_patent_app_number] => 10433349 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/433349 		Humanised antibodies and uses thereof Nov 28, 2001 Abandoned
Array ( [id] => 5969340 [patent_doc_number] => 20020091249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Human tumor suppressor polypeptides' [patent_app_type] => new [patent_app_number] => 09/970518 [patent_app_country] => US [patent_app_date] => 2001-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17160 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20020091249.pdf [firstpage_image] =>[orig_patent_app_number] => 09970518 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/970518 		Human tumor suppressor polypeptides Oct 2, 2001 Abandoned
09/831794 Influencing angiogenesis using CD66a Aug 2, 2001 Abandoned
09/806301 Novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers Jul 26, 2001 Abandoned
Array ( [id] => 5999782 [patent_doc_number] => 20020028472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Methods for identifying inhibitors of the anaphase promoting complex' [patent_app_type] => new [patent_app_number] => 09/893443 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8684 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028472.pdf [firstpage_image] =>[orig_patent_app_number] => 09893443 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/893443 		Methods for identifying inhibitors of the anaphase promoting complex Jun 28, 2001 Abandoned
09/744406 Allogeneic cellular immunogens useful as cancer vaccines Jan 21, 2001 Abandoned
Array ( [id] => 520054 [patent_doc_number] => 07189816 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-03-13 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 10/088639 [patent_app_country] => US [patent_app_date] => 2000-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 9751 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/189/07189816.pdf [firstpage_image] =>[orig_patent_app_number] => 10088639 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/088639 		Compounds Oct 25, 2000 Issued
09/635974 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists Aug 8, 2000 Abandoned
Array ( [id] => 634273 [patent_doc_number] => 07129330 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-31 [patent_title] => 'Multivalent antibody constructs' [patent_app_type] => utility [patent_app_number] => 09/674794 [patent_app_country] => US [patent_app_date] => 1999-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4830 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/129/07129330.pdf [firstpage_image] =>[orig_patent_app_number] => 09674794 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/674794 		Multivalent antibody constructs May 4, 1999 Issued
Array ( [id] => 650747 [patent_doc_number] => 07112324 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-26 [patent_title] => 'CD 19×CD3 specific polypeptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/673735 [patent_app_country] => US [patent_app_date] => 1999-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 22 [patent_no_of_words] => 16744 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/112/07112324.pdf [firstpage_image] =>[orig_patent_app_number] => 09673735 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/673735 		CD 19×CD3 specific polypeptides and uses thereof Apr 20, 1999 Issued
Array ( [id] => 5873457 [patent_doc_number] => 20020048578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'ANTIBODY VARIANTS' [patent_app_type] => new [patent_app_number] => 09/125460 [patent_app_country] => US [patent_app_date] => 1998-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9283 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20020048578.pdf [firstpage_image] =>[orig_patent_app_number] => 09125460 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/125460 		ANTIBODY VARIANTS Aug 18, 1998 Abandoned
Array ( [id] => 708149 [patent_doc_number] => 07060808 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-13 [patent_title] => 'Humanized anti-EGF receptor monoclonal antibody' [patent_app_type] => utility [patent_app_number] => 08/973065 [patent_app_country] => US [patent_app_date] => 1996-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 22 [patent_no_of_words] => 23870 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060808.pdf [firstpage_image] =>[orig_patent_app_number] => 08973065 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/973065 		Humanized anti-EGF receptor monoclonal antibody Jun 6, 1996 Issued
Array ( [id] => 6791578 [patent_doc_number] => 20030086922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'METHOD OF PROMOTING AN IMMUNE RESPONSE WITH A BISPECIFIC ANTIBODY' [patent_app_type] => new [patent_app_number] => 08/349489 [patent_app_country] => US [patent_app_date] => 1994-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10263 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20030086922.pdf [firstpage_image] =>[orig_patent_app_number] => 08349489 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/349489 		METHOD OF PROMOTING AN IMMUNE RESPONSE WITH A BISPECIFIC ANTIBODY Dec 1, 1994 Abandoned
Menu